Conditions: Keratoconus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 127
Healthy volunteers: no

Brief summary:
The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL), when used to treat keratoconus.

Detailed description:

Arms:
arm 1: Eyes randomized to the CXL treatment group with be treated with riboflavin and UV light. arm 2: Eyes in the control group will be treated with riboflavin only.

Interventions: intervention 1: The VEGA UV-A Illumination System intervention 2: Riboflavin
Intervention descriptions: intervention 1: This is a portable electronic device designed to deliver a dose of UV-A light to the treatment area intervention 2: Riboflavin is a solution that will be delivered to the treatment area

Protocol document: